🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 00534A102
- Market Cap
- Small Cap
- IPO
- 8/6/2021 · $17.00/share
- Previous Symbol
- ADGI (changed 9/13/2022)
- Previous Name
- Adagio Therapeutics, Inc.
Business: Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has been optimized using Adimab’s industry-leading antibody engineering capabilities and is designed to provide patients and clinicians with a powerful combination of potency, breadth, durable protection (via half-life extension), manufacturability and affordability.
Company Contact
- CEO
- Jeremy Gowler
- CFO
- William Duke
- Headquarters
- 1601 Trapelo Road, Suite 178, Waltham, MA 02451
- Phone
- 781-819-0080
- Investor Relations
- Chris Brinzey, ICR Westwicke · 339-970-2843 · chris.brinzey@westwicke.com